reaction8 of in situ generated enolate species prompted us
to investigate the cycloaddition with R,β-unsaturated
amide to afford dihydropyranone moieties, which are
important building blocks in the synthesis of natural
products, and biologically active compounds.9
The synthesis of an R,β-unsaturated amide could be
classically carried out from commercially available isatins.
Presumably, activation of the isatin C3ꢀO double bond
via a simple one-step WittigꢀHorner reaction results in the
formation of 2-oxoindolin-3-ylidenes in excellent yields.
Moreover, this strategy being based on the annulation of
indoles opens up a new avenue for the synthesis of fused
pyran[2,3-b]indole skeletons, one of the most important
heterocycles and key structural units of biologically active
alkaloids.10 Although significant advances have been
achieved in the development of these derivatives for the
synthesis of biologically important compounds,11 enantio-
selective variants are still very limited.
cis-enolates are thermodynamically more stable than
the trans forms by approximately 3.9ꢀ6.5 kcal/mol.7
In the active cis-enolate, the N-substituted group is
prone to be “trans” to the oxo group and this mode is
reinforced by the presence of the bulky triazolium moiety.
The stereochemistry of 2-oxoindolin-3-ylidenes in this
[4 þ 2] cycloaddition reaction proved to exhibit an
(E)-configuration.14 The cis-diastereoselectivity would
arise from a cis-enolate reacting as the dienophile with
(E)-2-oxoindolin-3-ylidenes via an endo-transition state.
In this transition state mode, the re-face is completely
blocked by the indane moiety of the carbene catalyst,
leaving the si-face more accessible for the [4 þ 2] cycload-
dition withthe 2-oxoindolin-3-ylidene substrate(Figure1).
A study that was carried out by Ye and co-workers
presented a formal [4 þ 2] cycloaddition of ketenes with
oxindoles yielding indole-fused dihydropyranones.12
However, the diastereo- and enantioselectivities obtained
were quite unsatisfactory.
To address the challenge of achieving high optical
purity, N-mesityl-substituted triazolium salt13 (refer to
cat.) was chosen as the catalyst for this reaction and
racemic R-chloroaldehyde 1 was used as the dienophile
precursor to generate in situ the enolate species from
elimination of HCl from the NHC-R-chloroaldehyde ad-
duct. We envisioned that excellent diastereoselectivities
and absolute stereochemistries can be rationalized due to
the highly preferred endo-cis-transition state. The hypoth-
esis was based on DFT calculations that determined that
Figure 1. Proposed transtion state.
To test the concept, we carried out the reaction using 2.0
equiv of R-chloroaldehyde 2a and 3-alkylenyloxindole 1a
with N-mesityl-substituted triazolium salt in the presence
of base. The results were summarized in Table 1. As
expected, 20 mol % of N-mesityl substituted triazolium
salt effectively promoted the reaction in the presence of
Et3N in dichloromethane at room temperature and deliv-
ered the desired product with excellent diastereo- and
enantioselectivity (Table 1, entry 1). Next, the use of
different basesand solvents wasevaluated for thisreaction.
DIPEA was found to slightly decrease the enantioselec-
tivity (entry 2). When DBU was employed, the yield
decreased dramatically even though there was no loss in
diastereo- and enantioselectivity (entry 3). We observed
that the inorganic bases were deemed to be unsuitable for
the reaction, as they led to lowered yields and enantio-
selectivities (entries 4 and 5).
The screening of solvents revealed that toluene was the
most ideal (entry 12), while ethyl acetate gave the worst
result with a 65% yield, 85% ee, and uncompromised
diastereoselectivity (entry 6). n-Hexane afforded compar-
able results to that of toluene with a prolonged reaction
time (18 h, entry 10). When the catalyst loading was
lowered to 10 mol %, similar results were obtained, albeit
with a longer reaction time (entry 13). However, when the
catalyst loading was further decreased to 5 mol %, a
prolonged reaction time (18 h) was required and it resulted
(7) For a computational study regarding NHC-catalyzed oxo-
DielsꢀAlder reaction, see: (a) Kaeobamrung, J.; Kozlowski, M. C.;
Bode, J. W. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 20661–20665. (b)
Yang, L.; Wang, F.; Lee, R.; Lv, Y.; Huang, K.-W.; Zhong, G.
Submitted.
(8) Other approaches to NHC-catalyzed oxo-DielsꢀAlder reactions:
(a) Zhang, Y.-R.; Lv, H.; Zhou, D.; Ye, S. Chem.;Eur. J. 2008, 14,
8473–8476. (b) Kobayashi, S.; Kinoshita, T.; Uehara, H.; Sudo, T.; Ryu,
I. Org. Lett. 2009, 11, 3934–3937. (c) Fang, X.; Chen, X.; Chi, Y. R. Org.
Lett. 2011, 13, 4708–4711. (d) Ling, K. B.; Smith, A. D. Chem. Commun.
2011, 47, 373–375.
(9) (a) Das, B.; Laxminarayana, K.; Krishnaiah, M.; Kumar, D. N.
Bioorg. Med. Chem. Lett. 2009, 22, 6396–6398. (b) Kasaplar, P.;
Yilmazer, O.; Cagir, A. Bioorg. Med. Chem. 2009, 1, 311–314. (c)
Hamilton, H. W.; Tait, B. D.; Gajda, C.; Hagen, S. E.; Ferguson, D.;
Lunney, E. A.; Pavlovsky, A.; Tummino, P. J. Bioorg. Med. Chem. Lett.
1996, 6, 719–724.
(10) (a) Dewick, P. M. Medicinal Natural Products: A Biosynthetic
Approach, 2nd ed.; Wiley: New York, 2002; pp 189200. (b) Gataullin,
R. R. J. Org. Chem. 2008, 45, 321–354.
(11) (a) Ohnuma, T.; Kasuya, H.; Kimura, Y.; Ban, Y. Heterocycles
1982, 17, 377–380. (b) Nakagawa, M.; Sodeoka, M.; Yamaguchi, K.;
Hino, T. Chem. Pharm. Bull. 1984, 32, 1373–1384. (c) Fritz, H.;
Losacker, P. Justus Liebigs Ann. Chem. 1967, 709, 135–150. (d) Feldman,
K. S.; Karatjas, A. G. Org. Lett. 2004, 6, 2849–2852. (e) Kam, T. S.; Tan,
S. J.; Ng, S. W.; Komiyama, K. Org. Lett. 2008, 10, 3749–3752. (f) Reh,
S.; Bergman, J. Tetrahedron 2005, 61, 3115–3123.
(12) Lv, H.; Chen, X.-Y.; Sun, L.-H.; Ye, S. J. Org. Chem. 2010, 75,
6973–6976.
(13) (a) For review of the chemistry of N-mesityl catalysts, see:
Chiang, P.-C.; Bode, J. W. TCI MAIL 2011, 149, 2–17. (b) For their
syntheses, see: Struble, J. R.; Bode, J. W. Org. Synth. 2010, 87, 362–376.
(c) For mechanistic studies, see: Mahatthananchai, J.; Bode, J. W. Chem.
Sci. 2012, 3, 192–197.
(14) (a) Long, D. R.; Richards, C. G.; Ross, M. S. F. J. Hetereocycl.
Chem. 1978, 15, 633–636. (b) Autrey, R. L.; Tahk, F. C. Tetrahedron
1967, 23, 901–917. (c) Jones, G.; Rae, W. J. Tetrahedron 1966, 22, 3021–
3026.
Org. Lett., Vol. 14, No. 11, 2012
2895